IMDX
Goldman Sachs’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-61,548
| Closed | -$19.8K | – | 5209 |
|
|
2022
Q4 | $19.8K | Sell |
61,548
-319,984
| -84% | -$103K | ﹤0.01% | 4892 |
|
|
2022
Q3 | $279K | Sell |
381,532
-160,451
| -30% | -$117K | ﹤0.01% | 4579 |
|
|
2022
Q2 | $487K | Buy |
541,983
+81,979
| +18% | +$73.7K | ﹤0.01% | 4395 |
|
|
2022
Q1 | $686K | Buy |
460,004
+24,964
| +6% | +$37.2K | ﹤0.01% | 4382 |
|
|
2021
Q4 | $944K | Buy |
435,040
+17,525
| +4% | +$38K | ﹤0.01% | 4078 |
|
|
2021
Q3 | $1.49M | Buy |
417,515
+33,662
| +9% | +$120K | ﹤0.01% | 3704 |
|
|
2021
Q2 | $2.2M | Buy |
383,853
+215,074
| +127% | +$1.23M | ﹤0.01% | 3433 |
|
|
2021
Q1 | $876K | Buy |
168,779
+14,001
| +9% | +$72.7K | ﹤0.01% | 4002 |
|
|
2020
Q4 | $370K | Sell |
154,778
-18,649
| -11% | -$44.6K | ﹤0.01% | 3986 |
|
|
2020
Q3 | $241K | Buy |
173,427
+142,060
| +453% | +$197K | ﹤0.01% | 3998 |
|
|
2020
Q2 | $60K | Buy |
31,367
+12,174
| +63% | +$23.3K | ﹤0.01% | 4237 |
|
|
2020
Q1 | $47K | Buy |
+19,193
| New | +$47K | ﹤0.01% | 4285 |
|
|
2018
Q3 | – | Sell |
-18,466
| Closed | -$47K | – | 4209 |
|
|
2018
Q2 | $47K | Sell |
18,466
-10,751
| -37% | -$27.4K | ﹤0.01% | 4065 |
|
|
2018
Q1 | $61K | Buy |
+29,217
| New | +$61K | ﹤0.01% | 4060 |
|
|
2017
Q3 | – | Sell |
-42,015
| Closed | -$218K | – | 4357 |
|
|
2017
Q2 | $218K | Buy |
42,015
+5,265
| +14% | +$27.3K | ﹤0.01% | 3947 |
|
|
2017
Q1 | $219K | Buy |
+36,750
| New | +$219K | ﹤0.01% | 3915 |
|
|
2016
Q3 | – | Sell |
-29,558
| Closed | -$105K | – | 4610 |
|
|
2016
Q2 | $105K | Buy |
29,558
+393
| +1% | +$1.4K | ﹤0.01% | 4109 |
|
|
2016
Q1 | $134K | Buy |
+29,165
| New | +$134K | ﹤0.01% | 3934 |
|